Lattice Biologics Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LBLTF research report →
Companywww.latticebiologics.com
Lattice Biologics Ltd. , a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops novel amniotic fluid-based products, such as AmnioBoost and AmnioBlast.
- CEO
- Donna Medina
- IPO
- 2010
- HQ
- Belgrade, MT, US
Price Chart
Valuation
- Market Cap
- $16.55K
- P/E
- -0.01
- P/S
- 0.01
- P/B
- -0.00
- EV/EBITDA
- -53.08
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 41.44%
- Op Margin
- -13.64%
- Net Margin
- -60.19%
- ROE
- 23.33%
- ROIC
- 13.09%
Growth & Income
- Revenue
- $2.46M · 12.56%
- Net Income
- $-1,483,000 · -46.54%
- EPS
- $-0.01 · -34.26%
- Op Income
- $-336,000
- FCF YoY
- -151.00%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.21
- Avg Volume
- 897.6
Get TickerSpark's AI analysis on LBLTF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our LBLTF Coverage
We haven't published any research on LBLTF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate LBLTF Report →